Integral Diagnostics upgraded by RBC Capital: "We have upgraded IDX to Outperform as we believe the stock has a positive near-term outlook and offers an appealing risk/reward profile. "Our PT has increased to $3.15/share (from $2.30/share) due to earnings revisions and a roll forward of our DCF valuation."
Integral Diagnostics upgraded by RBC Capital: "We have upgraded...
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
-0.025(4.13%) |
Mkt cap ! $238.1M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 61.5¢ | 57.0¢ | $651.8K | 1.108M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31668 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |